For each pharma applications, the guide allows you to choose different products by functionality, and by conformity to the main pharmacopeias.
CRYSMEB is a unique low methylated derivative of betacyclodextrin. The degree of methylation is controlled in such a manner that the derivative has an advantageous profile of solubilising power and biological tolerance.
CRYSMEB could be an alternative solution for cyclodextrin-drug formulations.
A technical brochure incorporating a general introduction to this type of excipient, with detailed information on the physical, chemical and microbiological characteristics of LYCASIN® 80/55. Its biological properties and examples of pharmaceutical applications are also included.